Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT ® Test by the Center for Medicare and Medicaid Services BOULDER, Colo.--( BUSINESS WIRE )-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has designated the Nodify CDT ® Test as an Advanced Diagnostic Laboratory Test (ADLT) effective June 30, 2023. Obtaini
July 6, 2023
· 4 min read